US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Provectus Biopharmaceuticals, Inc.

0.0680

-0.0040-5.56%

Volume:164.99K

Turnover:11.17K

Market Cap:28.58M

PE:-3.94

High:0.0720

Open:0.0675

Low:0.0621

Close:0.0720

52wk High:0.1517

52wk Low:0.0500

Shares:420.28M

Float Shares:386.66M

Volume Ratio:1.01

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0172

EPS(LYR):-0.0213

ROE:22.69%

ROA:-623.13%

PB:-4.64

PE(LYR):-3.19

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Provectus announces publication of preclinical research on PV-10

BRIEF-Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10

Provectus Biopharmaceuticals Initiates Preclinical Study of Oral Pv-10 in Bladder Cancer

THOMSON REUTERS

Provectus Q2 Sales $57.480K Down From $254.991K YoY

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PVCT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","market":"US","secType":"STK","nameCN":"Provectus Biopharmaceuticals, Inc.","latestPrice":0.068,"timestamp":1764968400000,"preClose":0.072,"halted":0,"volume":164985,"delay":15,"floatShares":386656900,"shares":420279879,"eps":-0.01724,"marketStatus":"Market Closed","change":-0.004,"latestTime":"12-05 16:00:00 EST Delay","open":0.0675,"high":0.072,"low":0.0621,"amount":11169.949119999996,"amplitude":0.1375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.01724,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.072,"volumeRatio":1.0073131489602942},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","floatShares":386656900,"roa":"-623.13%","roe":"22.69%","lyrEps":-0.021324,"volumeRatio":1.0073131489602942,"shares":420279879,"dividePrice":0,"high":0.072,"amplitude":0.1375,"preClose":0.072,"low":0.0621,"week52Low":0.05,"pbRate":"-4.64","psRate":"81.55","week52High":0.151655,"institutionHeld":0.0006,"latestPrice":0.068,"eps":-0.01724,"divideRate":0,"volume":164985,"delay":15,"ttmEps":-0.01724,"open":0.0675,"prevYearClose":0.1201,"prevWeekClose":0.0632,"prevMonthClose":0.0632,"prevQuarterClose":0.089,"fiveDayClose":0.0632,"twentyDayClose":0.064,"sixtyDayClose":0.0681},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-22","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVCT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVCT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574942152","title":"Provectus announces publication of preclinical research on PV-10","url":"https://stock-news.laohu8.com/highlight/detail?id=2574942152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574942152?lang=en_us&edition=fundamental","pubTime":"2025-10-09 20:20","pubTimestamp":1760012424,"startTime":"0","endTime":"0","summary":"Provectus (PVCT) Biopharmaceuticals announced the publication of independent preclinical research by Aru Narendran, MD, PhD and colleagues at the U...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/provectus-announces-publication-of-preclinical-research-on-pv-10-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/provectus-announces-publication-of-preclinical-research-on-pv-10-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PVCT"],"gpt_icon":0},{"id":"2571733337","title":"BRIEF-Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10","url":"https://stock-news.laohu8.com/highlight/detail?id=2571733337","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571733337?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:10","pubTimestamp":1759147806,"startTime":"0","endTime":"0","summary":"BRIEF-Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10Sept 29 (Reuters) - Provectus Biopharmaceuticals Inc PVCT.PK:PROVECTUS BIOPHARMACEUTICALS INITIATES PRECLINICAL STUDY OF ORA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA1WTCV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVCT","BK4007"],"gpt_icon":0},{"id":"2571338574","title":"Provectus Biopharmaceuticals Initiates Preclinical Study of Oral Pv-10 in Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2571338574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571338574?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:00","pubTimestamp":1759147201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA1WTCV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVCT","BK4007"],"gpt_icon":0},{"id":"2559676189","title":"Provectus Q2 Sales $57.480K Down From $254.991K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676189","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559676189?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:53","pubTimestamp":1755208385,"startTime":"0","endTime":"0","summary":"Provectus (OTC:PVCT) reported $57.480 thousand in sales this quarter. This is a 77.46 percent decrease over sales of $254.991 thousand the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47143187/provectus-q2-sales-57-480k-down-from-254-991k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Provectus Q2 Sales $57.480K Down From $254.991K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVCT"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PVCT\",params:#limit:6,delay:false,,,undefined,":[]}}